SS
RIGL icon

SBI Securities’s Rigel Pharmaceuticals RIGL Stock Holding History

SBI Securities’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.44K Buy
238
+140
+143% +$4.71K ﹤0.01% 1919
2025
Q4 		$4.2K Buy
98
+64
+188% +$2.41K ﹤0.01% 2093
2025
Q3 		$963 Hold
34
– – ﹤0.01% 2702
2025
Q2 		$637 Hold
34
– – ﹤0.01% 2864
2025
Q1 		$612 Sell
34
-135
-80% -$2.74K ﹤0.01% 2784
2024
Q4 		$2.84K Buy
+169
New +$3.24K ﹤0.01% 2151

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SBI Securities's RIGL Position: Q1 2026 in Review

SBI Securities increased its Rigel Pharmaceuticals (RIGL) stake by 143% in Q1 2026, buying an estimated $4.71K and bringing the position to 238 shares worth $6.44K. The position accounts for ﹤0.01% of the portfolio, ranked #1919.

SBI Securities first reported a position in RIGL in Q4 2024 and has held it in 6 quarters since. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • SBI Securities held 238 shares of Rigel Pharmaceuticals worth $6.44K as of Q1 2026.
  • SBI Securities bought 140 Rigel Pharmaceuticals shares in Q1 2026, an estimated $4.71K.
  • Rigel Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #1919 holding.
  • SBI Securities first reported a position in Rigel Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.